- Home
- MVST vs SMLR Comparison
MVST vs SMLR Comparison
Compare MVST & SMLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVST
- SMLR
- Stock Information
- Founded
- MVST 2006
- SMLR 2007
- Country
- MVST United States
- SMLR United States
- Employees
- MVST 2006
- SMLR N/A
- Industry
- MVST Industrial Machinery/Components
- SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MVST Miscellaneous
- SMLR Health Care
- Exchange
- MVST Nasdaq
- SMLR Nasdaq
- Market Cap
- MVST 227.7M
- SMLR 289.5M
- IPO Year
- MVST N/A
- SMLR 2014
- Fundamental
- Price
- MVST $0.72
- SMLR $44.48
- Analyst Decision
- MVST Buy
- SMLR
- Analyst Count
- MVST 4
- SMLR 0
- Target Price
- MVST $4.50
- SMLR N/A
- AVG Volume (30 Days)
- MVST 66.9M
- SMLR 430.3K
- Earning Date
- MVST 11-12-2024
- SMLR 11-04-2024
- Dividend Yield
- MVST N/A
- SMLR N/A
- EPS Growth
- MVST N/A
- SMLR N/A
- EPS
- MVST N/A
- SMLR 2.04
- Revenue
- MVST $370,989,000.00
- SMLR $58,938,000.00
- Revenue This Year
- MVST $28.09
- SMLR N/A
- Revenue Next Year
- MVST $51.36
- SMLR N/A
- P/E Ratio
- MVST N/A
- SMLR $21.82
- Revenue Growth
- MVST 39.03
- SMLR N/A
- 52 Week Low
- MVST $0.15
- SMLR $20.88
- 52 Week High
- MVST $1.55
- SMLR $58.78
- Technical
- Relative Strength Index (RSI)
- MVST 80.24
- SMLR 64.02
- Support Level
- MVST $0.17
- SMLR $36.23
- Resistance Level
- MVST $1.05
- SMLR $58.78
- Average True Range (ATR)
- MVST 0.10
- SMLR 5.07
- MACD
- MVST 0.07
- SMLR 1.15
- Stochastic Oscillator
- MVST 63.07
- SMLR 51.63
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extend from core battery chemistry to battery packs.
About SMLR Semler Scientific Inc.
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.